{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:29:44Z","timestamp":1790771384280,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.ejso.2020.01.016","type":"journal-article","created":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T19:53:15Z","timestamp":1578685995000},"page":"789-795","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Novel staging system using carbohydrate antigen (CA) 19-9 in extra-hepatic cholangiocarcinoma and its implications on overall survival"],"prefix":"10.1016","volume":"46","author":[{"given":"Sri Harsha","family":"Tella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuhya","family":"Kommalapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhartha","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Bergquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Durgin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitesh","family":"Borad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean P.","family":"Cleary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Truty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Mahipal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2020.01.016_bib1","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1634\/theoncologist.2015-0446","article-title":"Forty-year trends in cholangiocarcinoma incidence in the U.S.: intrahepatic disease on the rise","volume":"21","author":"Saha","year":"2016","journal-title":"The Oncologist"},{"key":"10.1016\/j.ejso.2020.01.016_bib2","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","article-title":"Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma","volume":"60","author":"Bridgewater","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.ejso.2020.01.016_bib3","doi-asserted-by":"crossref","first-page":"v28","DOI":"10.1093\/annonc\/mdw324","article-title":"Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Valle","year":"2016","journal-title":"Ann Oncol : Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.ejso.2020.01.016_bib4","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1093\/annonc\/mds077","article-title":"Survival analysis and prognostic nomogram for patients undergoing resection of extrahepatic cholangiocarcinoma","volume":"23","author":"van der Gaag","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2020.01.016_bib5","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1080\/13651820801992575","article-title":"Surgery for extrahepatic cholangiocarcinoma: predictors of survival","volume":"10","author":"Kloek","year":"2008","journal-title":"HPB"},{"key":"10.1016\/j.ejso.2020.01.016_bib6","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1245\/s10434-010-1529-7","article-title":"Preoperative serum CA 19-9 level as a predictive factor for recurrence after curative resection in biliary tract cancer","volume":"18","author":"Chung","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.01.016_bib7","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1477-2574.2009.00149.x","article-title":"Elevated CA 19-9 portends poor prognosis in patients undergoing resection of biliary malignancies","volume":"12","author":"Hatzaras","year":"2010","journal-title":"HPB"},{"key":"10.1016\/j.ejso.2020.01.016_bib8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/bjs.10415","article-title":"Prognostic value of carbohydrate antigen 19-9 in patients undergoing resection of biliary tract cancer","volume":"104","author":"Yamashita","year":"2017","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2020.01.016_bib9","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/jso.24381","article-title":"Implications of CA19-9 elevation for survival, staging, and treatment sequencing in intrahepatic cholangiocarcinoma: a national cohort analysis","volume":"114","author":"Bergquist","year":"2016","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2020.01.016_bib10","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/jso.23666","article-title":"Elevated perioperative serum CA 19-9 levels are independent predictors of poor survival in patients with resectable cholangiocarcinoma","volume":"110","author":"Kondo","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2020.01.016_bib11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jamcollsurg.2016.02.009","article-title":"Carbohydrate antigen 19-9 elevation in anatomically resectable, early stage pancreatic cancer is independently associated with decreased overall survival and an indication for neoadjuvant therapy: a national cancer database study","volume":"223","author":"Bergquist","year":"2016","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.ejso.2020.01.016_bib12","first-page":"5489","article-title":"Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin","volume":"43","author":"Magnani","year":"1983","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejso.2020.01.016_bib13","first-page":"515","article-title":"Concordance analysis: part 16 of a series on evaluation of scientific publications","volume":"108","author":"Kwiecien","year":"2011","journal-title":"Dtsch Arzteblatt"},{"key":"10.1016\/j.ejso.2020.01.016_bib14","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1001\/jama.1982.03320430047030","article-title":"Evaluating the yield of medical tests","volume":"247","author":"Harrell","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.ejso.2020.01.016_bib15","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/sim.1802","article-title":"Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation","volume":"23","author":"Pencina","year":"2004","journal-title":"Stat Med"},{"key":"10.1016\/j.ejso.2020.01.016_bib16","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/sim.6370","article-title":"Comparing two correlated C indices with right-censored survival outcome: a one-shot nonparametric approach","volume":"34","author":"Kang","year":"2015","journal-title":"Stat Med"},{"key":"10.1016\/j.ejso.2020.01.016_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/sim.4085","article-title":"Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers","volume":"30","author":"Pencina","year":"2011","journal-title":"Stat Med"},{"key":"10.1016\/j.ejso.2020.01.016_bib18","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s11605-016-3180-5","article-title":"Prognostic impact of the initial postoperative CA19-9 level in patients with extrahepatic bile duct cancer","volume":"20","author":"Kato","year":"2016","journal-title":"J\u00a0Gastrointest Surg : Off J Soc Surg Aliment Tract"},{"key":"10.1016\/j.ejso.2020.01.016_bib19","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1023\/A:1018532409041","article-title":"Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer","volume":"14","author":"Kannagi","year":"1997","journal-title":"Glycoconj J"},{"key":"10.1016\/j.ejso.2020.01.016_bib20","doi-asserted-by":"crossref","first-page":"8132","DOI":"10.1073\/pnas.0402088101","article-title":"Hypoxia induces adhesion molecules on cancer cells: a missing link between Warburg effect and induction of selectin-ligand carbohydrates","volume":"101","author":"Koike","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejso.2020.01.016_bib21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1349-7006.2004.tb03219.x","article-title":"Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis","volume":"95","author":"Kannagi","year":"2004","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ejso.2020.01.016_bib22","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.hpb.2018.04.005","article-title":"Serum tumor markers enhance the predictive power of the AJCC and LCSGJ staging systems in resectable intrahepatic cholangiocarcinoma","volume":"20","author":"Sasaki","year":"2018","journal-title":"HPB"},{"key":"10.1016\/j.ejso.2020.01.016_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.21037\/tgh.2019.03.06","article-title":"The power to predict with biomarkers: carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen (CEA) serum markers in intrahepatic cholangiocarcinoma","volume":"4","author":"Jaklitsch","year":"2019","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1016\/j.ejso.2020.01.016_bib24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/hpb.12150","article-title":"Neoadjuvant therapy for downstaging of locally advanced hilar cholangiocarcinoma: a systematic review","volume":"16","author":"Grendar","year":"2014","journal-title":"HPB"},{"key":"10.1016\/j.ejso.2020.01.016_bib25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","article-title":"Cholangiocarcinoma - evolving concepts and therapeutic strategies","volume":"15","author":"Rizvi","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ejso.2020.01.016_bib26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2217\/hep.15.43","article-title":"Neoadjuvant treatment of biliary tract cancer: state-of-the-art and new perspectives","volume":"3","author":"Imperatori","year":"2016","journal-title":"Hepatic Oncol."},{"key":"10.1016\/j.ejso.2020.01.016_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10010024","article-title":"Contemporary management of localized resectable pancreatic cancer","volume":"10","author":"Kommalapati","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.ejso.2020.01.016_bib28","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s12885-019-5460-4","article-title":"Decreased serum carbohydrate antigen 19-9 levels after neoadjuvant therapy predict a better prognosis for patients with pancreatic adenocarcinoma: a multicenter case-control study of 240 patients","volume":"19","author":"Aoki","year":"2019","journal-title":"BMC Canc"},{"key":"10.1016\/j.ejso.2020.01.016_bib29","article-title":"Factors predicting response, perioperative outcomes, and survival following total neoadjuvant therapy for borderline\/locally advanced pancreatic cancer","author":"Truty","year":"2019","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2020.01.016_bib30","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s11605-016-3149-4","article-title":"CA19-9 normalization during pre-operative treatment predicts longer survival for patients with locally progressed pancreatic cancer","volume":"20","author":"Williams","year":"2016","journal-title":"J\u00a0Gastrointest Surg : Off J Soc Surg Aliment Tract"},{"key":"10.1016\/j.ejso.2020.01.016_bib31","article-title":"Importance of normalization of CA19-9 levels following neoadjuvant therapy in patients with localized pancreatic cancer","author":"Tsai","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2020.01.016_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2019.03.023","article-title":"Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: a propensity score matched analysis","author":"Yadav","year":"2019","journal-title":"Eur J Surg Oncol: Br Assoc Surg Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320300202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320300202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:33:01Z","timestamp":1760059981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798320300202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0748798320300202"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2020.01.016","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel staging system using carbohydrate antigen (CA) 19-9 in extra-hepatic cholangiocarcinoma and its implications on overall survival","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2020.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}